Recently, significant progress has been made in elucidating the mechanism underlying the development of glucocorticoid resistance in COPD, wherein glucocorticoid receptor and isoform expression levels, PI3K/AKT signaling pathway, and histone deacetylase expression levels were reported to play a major role [25]. Here, NR3C1 is linked to chronic obstructive pulmonary disease.